Copertina

Trends in fentanyl‐containing drug samples seized by law enforcement agencies across Canada

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	Shaleesa Ledlie, Ria Garg, Pamela Leece, Gillian Kolla, Elaine Hyshka, Mina Tadrous, Tara Gomes
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2026
Soggetti:	Addiction
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Broad evidence of xylazine in the UK illicit drug market beyond heroin supplies: Triangulating from toxicology, drug‐testing and law enforcement
di: Caroline S. Copeland, et al.
Pubblicazione: (2024)

Transcriptional signatures of fentanyl use in the mouse ventral tegmental area
di: Megan E. Fox, et al.
Pubblicazione: (2024)

High temporal resolution monitoring of illicit drug consumption across England via wastewater analysis
di: Helena Rapp‐Wright, et al.
Pubblicazione: (2026)

Case Series: Magnitude and duration of fentanyl and xylazine detection in the urine of persons with opioid use disorder
di: Helen E. Bird, et al.
Pubblicazione: (2025)

Craving self‐reports as outcome measures in drug addiction trials: A systematic review of ClinicalTrials.gov
di: Matin Toulami, et al.
Pubblicazione: (2025)

Navigating new norms: Addiction specialists' perspectives on opioid use disorder treatments and policy challenges in the fentanyl era
di: Jeremy Weleff, et al.
Pubblicazione: (2024)

Commentary on ter Laak et al .: The importance of drug market information and differentiating drug use patterns
di: Rory Verhagen, et al.
Pubblicazione: (2024)

Longitudinal analysis of alcohol consumption pattern and menopause‐specific quality of life in middle‐aged women undergoing the menopausal transition
di: Ria Kwon, et al.
Pubblicazione: (2025)

Cannabis use patterns and comparison trends in Canada
di: Benedikt Fischer, et al.
Pubblicazione: (2025)

Changing trends in drug overdose mortality in Spain, 2001–2022
di: Florencia Giné, et al.
Pubblicazione: (2025)

Decentering alcohol: Non‐drug pleasure and reinforcement as an alternative target
di: Samuel F. Acuff, et al.
Pubblicazione: (2025)

Tobacco–cannabis co‐use in adults ≥50: Trends, medical marijuana laws, and cessation implications—Letter to the Editor
di: Gabriel P. A. Costa, et al.
Pubblicazione: (2025)

Commentary on Pardo et al.: Whatever the past situation, drug precursor chemicals may in future represent an important source for synthetic drug production in Afghanistan and surrounding countries
di: Alexander Soderholm, et al.
Pubblicazione: (2024)

Isaac Campos. Home grown: Marijuana and the origins of Mexico's war on drugs
di: Wayne Hall, et al.
Pubblicazione: (2025)

Recovery support services as part of the continuum of care for alcohol or drug use disorders
di: Ed Day, et al.
Pubblicazione: (2025)

Naloxone dosing: An evolving unregulated drug landscape, care setting considerations, and the need for research
di: James S. H. Wong, et al.
Pubblicazione: (2025)

Fatal drug overdoses in healthcare workers: A thematic framework analysis of coroner reports
di: Thikra Algahtani, et al.
Pubblicazione: (2025)

Commentary on Nieto et al .: The heterogeneity of drug craving and considerations as a treatment endpoint
di: Justin C. Strickland, et al.
Pubblicazione: (2026)

The association of methadone use with physical function and frailty among persons who inject drugs
di: Grace L. Kulik, et al.
Pubblicazione: (2025)

Trends in gamma‐hydroxybutyrate use, harms and treatment in Australia, 2013 to 2024
di: Amy Peacock, et al.
Pubblicazione: (2026)

Empirically contrasting urine drug screening‐based opioid use disorder treatment outcome definitions
di: Laura Brandt, et al.
Pubblicazione: (2024)

Comparison of strength and adulteration between illicit drugs obtained from cryptomarkets versus off‐line
di: Leigh Coney, et al.
Pubblicazione: (2024)

Characteristics of drug‐related deaths among individuals identified as LGBTQ+ in the United Kingdom, 1997–2024
di: Emmert Roberts, et al.
Pubblicazione: (2025)

Temporal and geographical patterns of nitazene detections in drug samples and biospecimens in the United States, 2019–2024
di: David T. Zhu, et al.
Pubblicazione: (2026)

Working with, learning from and giving back: Principles for collaborative research with people who use drugs
di: Magdalena Harris
Pubblicazione: (2026)

Alcohol and drug use and attainment of pregnancy preferences in the southwestern United States: A longitudinal cohort study
di: Sarah Raifman, et al.
Pubblicazione: (2025)

A systematic review of reviews on comprehensive community initiatives to prevent or reduce alcohol and other drug harms
di: Peter John Gates, et al.
Pubblicazione: (2025)

Trajectories of genetic risk across dimensions of alcohol use behaviors
di: Jeanne E. Savage, et al.
Pubblicazione: (2025)

Commentary on Andreacchi et al.: Policy responses to shifting epidemiological trends in alcohol use in Canada
di: Carolin Kilian, et al.
Pubblicazione: (2024)

Trends in substance use and related harms among older adults in high‐income countries
di: Rachel Sutherland, et al.
Pubblicazione: (2024)

Research is needed to guide contingency management implementation across populations and settings
di: Richard Rawson, et al.
Pubblicazione: (2024)

Packaging of disposable vaping products and e‐liquids in England, Canada and the United States: A content analysis
di: Matilda K. Nottage, et al.
Pubblicazione: (2024)

Prescribing practices in opioid agonist treatment and changes in compliance to clinical dosing guidelines in British Columbia, Canada
di: Brenda Carolina Guerra‐Alejos, et al.
Pubblicazione: (2024)

Among people who use heroin, tobacco smoking and illegal drugs cause a similar number of premature deaths
di: Dan Lewer, et al.
Pubblicazione: (2025)

Commentary on Copeland et al.: Does xylazine in the United Kingdom foreshadow a European synthetic polysubstance drug crisis?
di: Joseph R. Friedman
Pubblicazione: (2024)

Trends in hallucinogen‐associated emergency department visits and hospitalizations in California, USA, from 2016 to 2022
di: Nicolas Garel, et al.
Pubblicazione: (2024)

Age, period and cohort effects of heavy episodic drinking by sex/gender and socioeconomic position in Canada, 2000–2021
di: Alessandra T. Andreacchi, et al.
Pubblicazione: (2024)

Changes in prenatal cannabis‐related diagnosed disorders after the Cannabis Act and the COVID‐19 pandemic in Quebec, Canada
di: José Ignacio Nazif‐Munoz, et al.
Pubblicazione: (2024)

How effective are remote and/or digital interventions as part of alcohol and drug treatment and recovery support? A systematic review and meta‐analysis
di: Irene Kwan, et al.
Pubblicazione: (2025)

Differences in heroin overdose risk associated with the unregulated drug market: Insights from a supervised injecting facility in Melbourne, Australia
di: Nathan C. Stam, et al.
Pubblicazione: (2024)